Origin Therapeutics Holdings (XCNQ:ORIG) Purchase Of Business : C$0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Purchase Of Business?

Origin Therapeutics Holdings's purchase of business for the three months ended in Jun. 2023 was C$0.00 Mil. It means Origin Therapeutics Holdings spent C$0.00 Mil on purchasing business. Origin Therapeutics Holdings's purchase of business for the trailing twelve months (TTM) ended in Jun. 2023 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Mar. 2023 ), Origin Therapeutics Holdings spent the same money on purchasing business in Jun. 2023 (C$0.00 Mil).

Origin Therapeutics Holdings Purchase Of Business Historical Data

The historical data trend for Origin Therapeutics Holdings's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Purchase Of Business Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Purchase Of Business

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Purchase Of Business	Get a 7-Day Free Trial				-	-	-	-	-

Origin Therapeutics Holdings Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Origin Therapeutics Holdings Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.